Intended for healthcare professionals
Our CompanySubscribeMy AccountLogin

Atorvastatin versus placebo in patients with covid-19 in intensive care

Atorvastatin versus placebo in patients with covid-19 in intensive care

In this randomized trial, atorvastatin compared with placebo was not associated with a significant reduction venous or arterial thrombosis, treatment with extracorporeal membrane oxygenation, or all cause mortality

Editor's ChoicePrioritising health to save livesRead our latest coverage of the covid-19 pandemic
Management and outcomes of extreme preterm birth

This new clinical update provides a broad overview of extreme preterm birth epidemiology, recent changes, and best practices in obstetric and neonatal management

practice  |  Jan 10
Management and outcomes of extreme preterm birth

This new clinical update provides a broad overview of extreme preterm birth epidemiology, recent changes, and best practices in obstetric and neonatal management

practice

Jan 10

Latest articles

News

Covid-19: Omicron variant

UK Jobs

H&F Partnership: Salaried GP opportunities – Hammersmith & Fulham Partnership PCN

Current issue

latest issue
All articlesPast issues

Most read

1.

Community

Latest responses

View more

What are your thoughts?

Altmetrics

Altmetric Badge
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Nov 2, 2021